1. Home
  2. OGN vs FOR Comparison

OGN vs FOR Comparison

Compare OGN & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.68

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo Forestar Group Inc

FOR

Forestar Group Inc

N/A

Current Price

$27.06

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OGN
FOR
Founded
1923
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
OGN
FOR
Price
$13.68
$27.06
Analyst Decision
Hold
Buy
Analyst Count
5
3
Target Price
$11.40
$32.67
AVG Volume (30 Days)
3.1M
105.4K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
0.95
1.63
Revenue
$6,216,000,000.00
$1,662,400,000.00
Revenue This Year
$0.45
$0.34
Revenue Next Year
$1.67
$7.73
P/E Ratio
$14.38
$16.53
Revenue Growth
N/A
10.14
52 Week Low
$5.69
$22.81
52 Week High
$13.79
$32.06

Technical Indicators

Market Signals
Indicator
OGN
FOR
Relative Strength Index (RSI) 45.85 38.32
Support Level $13.46 $26.01
Resistance Level $13.79 $27.87
Average True Range (ATR) 0.03 0.66
MACD -0.02 -0.12
Stochastic Oscillator 19.35 23.98

Price Performance

Historical Comparison
OGN
FOR

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

Share on Social Networks: